News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
371
Sources here
23
Companies here
8
Search results Stored financial headlines

Active search

371 matching headlines

Ticker or company: AMARMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Florida State Partners with Aramark as Athletics Food Provider

Florida State University has announced a partnership with Aramark to be the exclusive food provider for all its athletics venues. This collaboration aims to synchronize food services across campus, offering a consistent and elevated dining experience for fans on game days and providing daily …

ARMK main company
Sharemaestro market context Trend signal active 52 weeks +57.1% ARMK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALAMAR BIOSCIENCES INC : STIFEL RAISES TARGET PRICE TO $32 FROM $28

Stifel has increased its target price for ALAMAR BIOSCIENCES INC to $32 from $28. This update, reported by Reuters, reflects an analyst's revised valuation for the company. The article emphasizes that the content represents the author's opinion and should not be used as investment …

ALMR main company
Sharemaestro market context Stored weekly price path 18 weeks +50.7% ALMR stored weekly price path from 17 Apr 2026 to 14 Aug 2026

Aramark beats fiscal Q3 estimates as revenue growth accelerates

Graph showing growth ©Adobe Stock Images Aramark (NYSE:ARMK) reported better-than-expected fiscal third-quarter 2026 results on Tuesday, supported by broad-based organic growth, strong new business wins and record client retention. Adjusted earnings per share reached $0.52, beating the analyst consensus of $0.48 by $0.04. Revenue …

ARMK main company
Sharemaestro market context Trend signal active 52 weeks +57.1% ARMK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aramark (NYSE:ARMK) Surprises With Q2 CY2026 Sales

Aramark (NYSE:ARMK) Surprises With Q2 CY2026 Sales Food and facilities services provider Aramark (NYSE:ARMK) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 9.3% year on year to $5.06 billion. Its non-GAAP profit of $0.52 per share was 7.2% above …

ARMK main company
Sharemaestro market context Trend signal active 52 weeks +57.1% ARMK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aramark Q3 revenue rises 9% to $5.1 billion

Aramark (ARMK) reported a 9% year-over-year revenue increase to $5.1 billion for Q3 fiscal 2026, with diluted EPS up 34% to $0.36. The company raised its fiscal 2026 organic revenue growth outlook to 9-10% and declared a quarterly dividend of $0.12 per share. Insider …

ARMK main company
Sharemaestro market context Trend signal active 52 weeks +57.1% ARMK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aramark: Fiscal Q3 Earnings Snapshot

Aramark Holdings Corp. reported strong fiscal third-quarter results, with net income reaching $97.7 million, or 36 cents per share. Adjusted earnings of 52 cents per share surpassed Wall Street expectations, as did the company's revenue of $5.06 billion. Aramark's stock has seen significant growth, …

ARMK main company
Sharemaestro market context Trend signal active 52 weeks +57.1% ARMK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aramark Reports Third Quarter Earnings

YEAR-OVER-YEAR SUMMARY Note: As previously disclosed, the calendar shift resulting from the 53rd week in fiscal 2025 affects quarterly comparisons in fiscal 2026 Revenue +9%; Organic Revenue +9% Performance driven by broad-based net new business and base business momentum; Revenue growth would have increased …

ARMK main company
Sharemaestro market context Trend signal active 52 weeks +57.1% ARMK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $33.4, Implies 19% Upside

Alamar Biosciences, Inc.'s average 12-month price target has been increased from $31.8 to $33.4 by 5 analysts, with forecasts ranging from $31 to $35 per share. This new target implies approximately 19% potential upside based on the August 10 closing price. The consensus rating …

ALMR main company
Sharemaestro market context Stored weekly price path 18 weeks +50.7% ALMR stored weekly price path from 17 Apr 2026 to 14 Aug 2026

Alamar Biosciences, Inc. 2Q 2026: Revenue $29.4M, EPS $(0.22) — 10-Q Summary

Alamar Biosciences, Inc. reported its second-quarter 2026 results, showing revenue of $29.4 million, an 82% increase year-over-year, driven by a surge in consumables sales. Despite this growth, the company recorded a net loss of $13.2 million and a diluted loss per share of $(0.22). …

ALMR main company
Sharemaestro market context Stored weekly price path 18 weeks +50.7% ALMR stored weekly price path from 17 Apr 2026 to 14 Aug 2026

Aramark jumps after Q3 earnings beat and higher 2026 revenue outlook

Aramark (ARMK) stock rose 8.9% following a strong fiscal third-quarter report, with adjusted EPS surpassing consensus estimates and an increased full-year organic revenue growth outlook for 2026. The company reported significant year-over-year revenue growth, high client retention, and noted early success in its AI …

ARMK main company
Sharemaestro market context Trend signal active 52 weeks +57.1% ARMK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aramark Student Nutrition Schools Recognized by the Texas Department of Agriculture for Participation in the Farm Fresh Challenge

Aramark Student Nutrition has been recognized by the Texas Department of Agriculture for its participation in the Farm Fresh Challenge. This recognition highlights Aramark's commitment to providing fresh, locally sourced food options to students in Texas schools.

ARMK main company
Sharemaestro market context Trend signal active 52 weeks +57.1% ARMK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Costamare Bulkers (CMDB) Stock Chart and Price History 2026

This article provides the stock chart and price history for Costamare Bulkers (CMDB) as of August 10, 2026. It includes current stock price, market capitalization, trading volume, and a historical data table with daily figures. The page also offers various investment tools and research …

CMDB main company
Sharemaestro market context Trend signal active 52 weeks +89.7% CMDB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alamar outlines $116M-$120M 2026 revenue outlook while targeting 100+ instruments and $400,000+ pull-through

Earnings Call Insights: Alamar Biosciences (ALMR) Q2 2026 MANAGEMENT VIEW * “Q2 2026 was a strong quarter that reflects the momentum of our business,” said Co-Founder, Chairman & CEO Yuling Luo, highlighting that “Total revenue grew 82% year-over-year,” that “Consumable revenue accounted for 53% …

ALMR main company
Sharemaestro market context Stored weekly price path 18 weeks +50.7% ALMR stored weekly price path from 17 Apr 2026 to 14 Aug 2026

Alamar Biosciences FY26 sales guidance beats estimates

Alamar Biosciences (NASDAQ: ALMR) reported strong Q2 2026 results with an 82% revenue surge to $29.4 million, primarily driven by a 147% increase in consumable sales. The company raised its full-year 2026 revenue guidance to $116-$120 million, surpassing analyst estimates. Despite a widening net …

ALMR main company
Sharemaestro market context Stored weekly price path 18 weeks +50.7% ALMR stored weekly price path from 17 Apr 2026 to 14 Aug 2026

Alamar Biosciences expands proteomics partnership by 86,000 samples

Alamar Biosciences is expanding its partnership with the Alzheimer’s Disease Data Initiative and Gates Ventures to analyze an additional 86,000 plasma samples using its NULISAseq Neuro 220 panel. This expansion builds on a previous initiative that profiled over 55,000 samples, aiming for a total …

ALMR main company
Sharemaestro market context Stored weekly price path 18 weeks +50.7% ALMR stored weekly price path from 17 Apr 2026 to 14 Aug 2026

Alamar: Q2 Earnings Snapshot

Alamar Biosciences Inc. (ALMR) reported a Q2 loss of $13.2 million, or 22 cents per share, which surpassed Wall Street expectations of a 36-cent loss. The biotech company, specializing in proteomics, posted revenue of $29.4 million for the period and projects full-year revenue between …

ALMR main company
Sharemaestro market context Stored weekly price path 18 weeks +50.7% ALMR stored weekly price path from 17 Apr 2026 to 14 Aug 2026

Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance

Alamar Biosciences reported strong second-quarter 2026 financial results, with total revenue increasing by 82% to $29.4 million and consumable revenue growing by nearly 150% year-over-year. The company also launched new products, including a multiplexed immunoassay for eMTBR-tau and the NULISAseq™ Immune 340 Panel, and …

ALMR main company
Sharemaestro market context Stored weekly price path 18 weeks +50.7% ALMR stored weekly price path from 17 Apr 2026 to 14 Aug 2026

Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures

Alamar Biosciences has expanded its partnership with the Alzheimer’s Disease Data Initiative and Gates Ventures to profile an additional 86,000 plasma samples using its NULISAseq™ Neuro 220 panel. This collaboration aims to create the largest neurodegenerative disease dataset, encompassing over 140,000 samples by 2027, …

ALMR main company
Sharemaestro market context Stored weekly price path 18 weeks +50.7% ALMR stored weekly price path from 17 Apr 2026 to 14 Aug 2026

Aramark Q3 2026 Earnings Preview

* Aramark (ARMK [https://seekingalpha.com/symbol/ARMK]) is scheduled to announce Q3 earnings results on Tuesday, August 11th, before market open. * The consensus EPS Estimate is $0.48 [https://seekingalpha.com/symbol/ARMK/earnings/estimates] (+20.0% Y/Y) and the consensus Revenue Estimate is $4.94B (+6.7% Y/Y). * Over the last 2 years, ARMK …

ARMK main company
Sharemaestro market context Trend signal active 52 weeks +57.1% ARMK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aramark earnings on deck as investors eye Nexus potential By Investing.com

Aramark is set to report its fiscal third-quarter earnings, with investors keenly watching its core food services performance and the potential of its new data center venture, Aramark Nexus. Analysts expect adjusted EPS of 48 cents and revenue of $4.92 billion, as the stock …

ARMK main company
Sharemaestro market context Trend signal active 52 weeks +57.1% ARMK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Costamare Bulkers Holdings' (NYSE:CMDB) Earnings Seem To Be Promising

Costamare Bulkers Holdings (NYSE:CMDB) recently reported solid earnings, which were nonetheless impacted by a significant US$11m in unusual items during the last twelve months. Despite these deductions, the company's underlying earnings potential appears strong, and it returned to profit this year after a loss …

CMRE main company CMDB main company
Sharemaestro market context Price below Trend Line 52 weeks +27.8% · Next-week setup positive 55.5% CMRE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What To Expect From Aramark’s (ARMK) Q2 Earnings

Aramark (NYSE:ARMK), a food and facilities services provider, is set to announce its Q2 earnings this Tuesday. Analysts expect revenue growth of 6.7% year-on-year, improving from the 5.7% increase recorded in the same quarter last year, despite the company having missed Wall Street's revenue …

ARMK main company
Sharemaestro market context Trend signal active 52 weeks +57.1% ARMK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context